Recurrence of diseases following orthotopic liver transplantation

Area of Science:

• Hepatology
• Transplantation immunology
• Gastroenterology

Background:

• Liver transplantation outcomes have improved, yet disease recurrence poses a significant challenge.
• Hepatitis C recurrence is nearly universal post-transplantation, leading to higher graft failure and mortality rates.
• Other recurrent liver diseases like nonalcoholic steatohepatitis and primary sclerosing cholangitis also impact graft survival.

Purpose of the Study:

• To review the impact of various liver disease recurrences on post-liver transplantation outcomes.
• To highlight the challenges posed by hepatitis C recurrence and discuss controversial aspects of retransplantation.
• To emphasize the importance of clinical management in preventing and treating post-transplant disease recurrence.

Main Methods:

• Literature review of studies on liver transplant outcomes and disease recurrence.
• Analysis of recurrence rates and their impact on graft survival and mortality for different liver diseases.
• Discussion of current management strategies and future directions.

Main Results:

• Hepatitis C recurrence significantly increases graft failure and mortality risk; retransplantation remains controversial.
• Hepatitis B recurrence is reduced by prophylactic regimens; hepatocellular carcinoma recurrence has decreased with improved selection.
• Autoimmune liver diseases and primary biliary cirrhosis may have milder recurrences, but alcoholic liver disease recurrence with return to drinking worsens mortality due to comorbidities.

Conclusions:

• Disease recurrence remains a critical factor influencing long-term liver transplant success.
• While some diseases have manageable recurrence, others like hepatitis C present substantial challenges.
• Proactive clinical management is essential for mitigating the adverse effects of disease recurrence on transplant recipients.